UNASSIGNED: Peripheral blood mononuclear cells (PBMCs) were isolated from patients with Ps at treatment initiation and three months later. Samples were also collected from controls. Cells were stained using monoclonal antibodies. Flow cytometry assessed the fraction of cTfh (CD3+CD4+CXCR5+) and cTph (CD3+CD4+CXCR5-PD-1hi) cells..
UNASSIGNED: Flow cytometric analysis showed increased fractions of activated cTfh subsets including ICOS+ and ICOS+PD-1+ expressing cells, in patients compared to controls. Biologic blocking of IL-17A diminished the cTfh population. Furthermore, ICOS+ and ICOS+PD-1+ sub-populations were also inhibited. Finally, the cTph cell fraction significantly decreased after three months of successful treatment with biologics.
UNASSIGNED: Early anti-IL-17-mediated clinical remission in Ps is associated with decreased cTfh and cTph cell subpopulations.
■在治疗开始和三个月后,从P患者中分离出外周血单核细胞(PBMC)。还从对照收集样品。使用单克隆抗体对细胞进行染色。流式细胞术评估cTfh(CD3+CD4+CXCR5+)和cTph(CD3+CD4+CXCR5-PD-1hi)细胞的分数。.
■流式细胞术分析显示,包括ICOS+和ICOS+PD-1+表达细胞的活化cTfh亚群分数增加,与对照组相比,患者。IL-17A的生物阻断减少了cTfh群体。此外,ICOS+和ICOS+PD-1+亚群也被抑制。最后,cTph细胞分数在生物制剂成功治疗3个月后显著下降.
■早期抗IL-17介导的Ps临床缓解与cTfh和cTph细胞亚群减少相关。